DK31991D0 - Peptid og farmaceutisk praeparat indeholdende et saadant peptid - Google Patents

Peptid og farmaceutisk praeparat indeholdende et saadant peptid

Info

Publication number
DK31991D0
DK31991D0 DK031991A DK31991A DK31991D0 DK 31991 D0 DK31991 D0 DK 31991D0 DK 031991 A DK031991 A DK 031991A DK 31991 A DK31991 A DK 31991A DK 31991 D0 DK31991 D0 DK 31991D0
Authority
DK
Denmark
Prior art keywords
absent
thr
ser
gly
peptid
Prior art date
Application number
DK031991A
Other languages
English (en)
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Priority to DK031991A priority Critical patent/DK31991D0/da
Publication of DK31991D0 publication Critical patent/DK31991D0/da
Priority to IE920496A priority patent/IE69853B1/en
Priority to ZA921270A priority patent/ZA921270B/xx
Priority to DE69201438T priority patent/DE69201438T2/de
Priority to PCT/DK1992/000053 priority patent/WO1992014751A1/en
Priority to AU13770/92A priority patent/AU1377092A/en
Priority to ES92906394T priority patent/ES2070635T3/es
Priority to EP92906394A priority patent/EP0573538B1/en
Priority to AT92906394T priority patent/ATE118349T1/de
Priority to CA002101075A priority patent/CA2101075C/en
Priority to JP50548192A priority patent/JP3250804B2/ja
Priority to DK92906394.9T priority patent/DK0573538T3/da
Priority to GR950401025T priority patent/GR3015888T3/el
Priority to US08/481,840 priority patent/US5763406A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK031991A 1991-02-25 1991-02-25 Peptid og farmaceutisk praeparat indeholdende et saadant peptid DK31991D0 (da)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK031991A DK31991D0 (da) 1991-02-25 1991-02-25 Peptid og farmaceutisk praeparat indeholdende et saadant peptid
IE920496A IE69853B1 (en) 1991-02-25 1992-02-17 Peptides for treatment
ZA921270A ZA921270B (en) 1991-02-25 1992-02-21 Peptides for treatment
DK92906394.9T DK0573538T3 (da) 1991-02-25 1992-02-24 Peptider til behandling
ES92906394T ES2070635T3 (es) 1991-02-25 1992-02-24 Peptidos para tratamiento.
PCT/DK1992/000053 WO1992014751A1 (en) 1991-02-25 1992-02-24 Peptides for treatment
AU13770/92A AU1377092A (en) 1991-02-25 1992-02-24 Peptides for treatment
DE69201438T DE69201438T2 (de) 1991-02-25 1992-02-24 Als therapeutika geeignete peptide.
EP92906394A EP0573538B1 (en) 1991-02-25 1992-02-24 Peptides for treatment
AT92906394T ATE118349T1 (de) 1991-02-25 1992-02-24 Als therapeutika geeignete peptide.
CA002101075A CA2101075C (en) 1991-02-25 1992-02-24 Peptides for the treatment of conditions caused by herpes virus infections
JP50548192A JP3250804B2 (ja) 1991-02-25 1992-02-24 治療用ペプチド
GR950401025T GR3015888T3 (en) 1991-02-25 1995-04-19 Peptides for treatment.
US08/481,840 US5763406A (en) 1991-02-25 1995-06-07 Method for the treatment of conditions caused by herpes virus infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK031991A DK31991D0 (da) 1991-02-25 1991-02-25 Peptid og farmaceutisk praeparat indeholdende et saadant peptid

Publications (1)

Publication Number Publication Date
DK31991D0 true DK31991D0 (da) 1991-02-25

Family

ID=8092219

Family Applications (2)

Application Number Title Priority Date Filing Date
DK031991A DK31991D0 (da) 1991-02-25 1991-02-25 Peptid og farmaceutisk praeparat indeholdende et saadant peptid
DK92906394.9T DK0573538T3 (da) 1991-02-25 1992-02-24 Peptider til behandling

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92906394.9T DK0573538T3 (da) 1991-02-25 1992-02-24 Peptider til behandling

Country Status (13)

Country Link
US (1) US5763406A (da)
EP (1) EP0573538B1 (da)
JP (1) JP3250804B2 (da)
AT (1) ATE118349T1 (da)
AU (1) AU1377092A (da)
CA (1) CA2101075C (da)
DE (1) DE69201438T2 (da)
DK (2) DK31991D0 (da)
ES (1) ES2070635T3 (da)
GR (1) GR3015888T3 (da)
IE (1) IE69853B1 (da)
WO (1) WO1992014751A1 (da)
ZA (1) ZA921270B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
CA2172491A1 (en) * 1993-09-24 1995-03-30 Jurgen Michaelis Method for the treatment or prevention of eczema/dermatitis
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
US6458766B1 (en) 1998-12-15 2002-10-01 The Regents Of The University Of California Halovir, an antiviral marine natural product, and derivatives thereof
US6613507B1 (en) 2000-03-21 2003-09-02 Yu-an Chang Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications
US7374068B2 (en) * 2004-10-08 2008-05-20 Homax Products, Inc. Particulate materials for acoustic texture material
NZ597182A (en) 2009-05-22 2014-07-25 Genocea Biosciences Inc Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6055776B2 (ja) 2010-11-24 2016-12-27 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対するワクチン：免疫応答を誘発する組成物及び方法
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
WO2013078299A1 (en) 2011-11-23 2013-05-30 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
EP3519427A4 (en) 2016-09-28 2020-03-11 Genocea Biosciences Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES
US12036286B2 (en) 2021-03-18 2024-07-16 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds
PL448078A1 (pl) * 2024-03-22 2025-09-29 Uniwersytet Jagielloński Koniugat do stosowania w profilaktyce i leczeniu infekcji wywoływanych przez wirusa opryszczki pospolitej typu pierwszego

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190127A1 (en) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Immunotherapeutic polypeptide agents
US4585587A (en) * 1984-10-19 1986-04-29 Northwestern University Antigenic peptide compounds
IT1190433B (it) * 1985-12-11 1988-02-16 Prodotti Antibiotici Spa Peptidi correlati al lisozima
AU7544987A (en) * 1986-06-03 1988-01-11 Pert, C.B. Small peptides which inhibit binding to t-4 receptors
ATE96450T1 (de) * 1986-06-03 1993-11-15 Us Commerce Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
AU1808088A (en) * 1987-05-22 1988-12-21 Syntbiotech, Inc. Synthetic peptides and a method of treating aids
JPH0618777B2 (ja) * 1988-05-27 1994-03-16 アメリカ合衆国 精神神経性欠損症の治療に用いられる組成物
DE3841761A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides

Also Published As

Publication number Publication date
ZA921270B (en) 1992-11-25
US5763406A (en) 1998-06-09
AU1377092A (en) 1992-09-15
IE69853B1 (en) 1996-10-02
JP3250804B2 (ja) 2002-01-28
WO1992014751A1 (en) 1992-09-03
GR3015888T3 (en) 1995-07-31
DE69201438T2 (de) 1995-10-05
DE69201438D1 (en) 1995-03-23
CA2101075A1 (en) 1992-08-26
DK0573538T3 (da) 1995-06-26
IE920496A1 (en) 1992-08-26
EP0573538B1 (en) 1995-02-15
ATE118349T1 (de) 1995-03-15
ES2070635T3 (es) 1995-06-01
JPH06507386A (ja) 1994-08-25
EP0573538A1 (en) 1993-12-15
CA2101075C (en) 2003-04-22

Similar Documents

Publication Publication Date Title
DK31991D0 (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid
AU6819294A (en) Oral drug delivery compositions and methods
ATE386118T1 (de) Cnp-gen und vorläuferprotein aus schwein
NO942553D0 (no) Ny humanproteaseinhibitor av Kunitz-type og varianter derav
ES2193272T3 (es) Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen.
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
ATE392428T1 (de) Arzneimittel enthaltend analgetische peptide
AU3871993A (en) Treatment of tropical spastic paresis with peptide t
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
DK0960886T3 (da) Peptid T og beslægtede peptider til behandling af inflammation, herunder multipel sklerose
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
RU94046096A (ru) Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
CA2216704A1 (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция
RU2002124494A (ru) Ингибиторы интегрина αvβ6
TH35998A (th) Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น
RU94036770A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения домена, фармацевтическая композиция, применение домена
TH26711A (th) " สิ่งที่คล้ายกันของปัจจัยหลั่งฮอโมนของการเจริญเติบโต "

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment